Dupont Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-631
| Closed | -$518K | – | 692 |
|
|
2023
Q1 | $518K | Sell |
631
-631
| -50% | -$518K | 0.02% | 316 |
|
|
2022
Q4 | $911K | Sell |
1,262
-575
| -31% | -$415K | 0.04% | 398 |
|
|
2022
Q3 | $1.27M | Buy |
1,837
+95
| +5% | +$65.4K | 0.08% | 294 |
|
|
2022
Q2 | $1.03M | Sell |
1,742
-10
| -0.6% | -$5.91K | 0.05% | 409 |
|
|
2022
Q1 | $1.22M | Sell |
1,752
-1,680
| -49% | -$1.17M | 0.05% | 406 |
|
|
2021
Q4 | $2.17M | Sell |
3,432
-609
| -15% | -$385K | 0.08% | 239 |
|
|
2021
Q3 | $2.45M | Sell |
4,041
-1,002
| -20% | -$607K | 0.08% | 265 |
|
|
2021
Q2 | $2.82M | Buy |
5,043
+1,350
| +37% | +$754K | 0.07% | 263 |
|
|
2021
Q1 | $1.75M | Sell |
3,693
-1,080
| -23% | -$511K | 0.04% | 392 |
|
|
2020
Q4 | $2.31M | Sell |
4,773
-325
| -6% | -$157K | 0.05% | 299 |
|
|
2020
Q3 | $2.85M | Buy |
5,098
+280
| +6% | +$157K | 0.06% | 239 |
|
|
2020
Q2 | $3.01M | Buy |
4,818
+933
| +24% | +$582K | 0.07% | 226 |
|
|
2020
Q1 | $1.9M | Buy |
3,885
+818
| +27% | +$399K | 0.05% | 307 |
|
|
2019
Q4 | $1.15M | Buy |
3,067
+1,756
| +134% | +$660K | 0.03% | 531 |
|
|
2019
Q3 | $364K | Hold |
1,311
| – | – | 0.01% | 914 |
|
|
2019
Q2 | $410K | Hold |
1,311
| – | – | 0.01% | 870 |
|
|
2019
Q1 | $538K | Hold |
1,311
| – | – | 0.01% | 733 |
|
|
2018
Q4 | $490K | Buy |
1,311
+345
| +36% | +$129K | 0.01% | 739 |
|
|
2018
Q3 | $390K | Buy |
+966
| New | +$390K | 0.01% | 758 |
|
|
2018
Q1 | – | Sell |
-481
| Closed | -$181K | – | 1005 |
|
|
2017
Q4 | $181K | Buy |
481
+94
| +24% | +$35.4K | ﹤0.01% | 794 |
|
|
2017
Q3 | $173K | Sell |
387
-60
| -13% | -$26.8K | ﹤0.01% | 819 |
|
|
2017
Q2 | $220K | Buy |
+447
| New | +$220K | ﹤0.01% | 807 |
|